• Blog
  • HPV Vaccines Market Report

    HPV Vaccines Market Report

    HPV Vaccines Market Report
    Report code - SRHL244 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global HPV Vaccines Market, Dynamics, and Market Analysis
    See more...

    Impact of COVID-19 on HPV Vaccines Market

    Covid-19 has impacted the market dynamics, competition, and global...

    See more...

    Impact of COVID-19 on HPV Vaccines Market

    Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.

    Note: The summary below might not have included insights on covid impact since we have large number of reports.

    Market Insights

    The Global HPV Vaccines Market is projected to grow from USD 4.82 billion in 2020 to USD 11.79 billion by 2026 at a CAGR of over 16.1% during the forecast period.

    Figure: Global HPV Vaccines Market Size, 2020-2026 (USD Billion)

    HPV-Vaccines-Market-Forecast

    Wish to get a sample report? Click here.

    What is Human papillomavirus (HPV)?

    Human papillomavirus (HPV) infection is one of the most common sexually transmitted infections which is caused by HPV-related cancers, such as genital and cervical cancers. HPV infection vaccines are primarily used to prevent genital warts, cervical cancer, anal cancer, and vaginal cancer. Three commercially available HPV prevention vaccines, such as Gardasil 9 and Gardasil by Merck and Cervarix developed by GSK Plc, are known to be highly effective in preventing HPV infection and genital precancerous lesions.

    Key Players

    Key players operating in the global HPV vaccines market are-

    • Lumetrics (The U.S),
    • Marco (The U.S),
    • Voptica (Spain),
    • AMICO GROUP (UAE),
    • NIDEK (Japan),
    • Hanson Instruments (UK),
    • Alcon (Switzerland), Carl Zeiss (Germany),
    • Essilor (France), and Johnson & Johnson Visioncare Inc. (US).

    Market Dynamics

    The rising prevalence of cervical cancer among women is a prime factor augmenting the demand for HPV vaccines.

    • Moreover, the growing need to reduce HPV infections further adds emphasis to the market growth in the near future.
    • Furthermore, the government bodies in numerous countries are focusing on imposing stringent policies for supplying vaccines to prevent the burden of this disease thus boosting the product demand.
    • However, these vaccines are short in supply and are available in limited amounts thus fails to cater to the rising need, thus affecting the market expansion.

    Segment Analysis

    Type Trends

    By type, the global HPV vaccines market has been bifurcated into bivalent, polyvalent.

    • Under these, the polyvalent segment accounted for the highest market share in 2020 and is projected to grow at a moderate CAGR in the coming years.
    • This is mainly attributed to their low cost and performance efficiency and that they are highly popular especially in the developing countries of Asia Pacific, thus bolsters the segment growth.

    Regional Trends

    By region, the North American market witnessed the highest market share in 2020 and is estimated to register at a considerable CAGR during the review period. This is mainly attributed to the strong presence of well-established healthcare facilities, along with the ease in the availability of necessary resources. Moreover, people are aware of the presence of vaccines and related therapeutic procedures, thus augmenting the for vaccination and treatment, further boosting the regional growth.

    COVID-19 Impact on Global HPV Vaccines Market

    The outbreak of the COVID-19 virus had a devastating impact on the HPV vaccine industry. The healthcare industry is currently facing major challenges as it is unable to provide proper medical facilities to cater to the ever-growing coronavirus patient pool. With the stringent imposition of lockdown and social distance regulations, there were limited check-ups of women suffering from sexually transmitted diseases. During the pandemic period in 2020, around 342,000 women lost their lives due to cervical cancer. Thus, a poor healthcare system due to limited medical professionals and funding affected the market growth.

    Critical Questions Answered in the Report

    • What are the key trends in the global HPV vaccines market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global HPV vaccines market?
    • What are the key strategies adopted by the major vendors to lead in the global HPV vaccines market?
    • What is the market share of the top vendors?

    Want to know the full scope of the report? Register Here

    Target Audience

    Here is the list of the group of customers that the HPV Vaccine market hopes to have the greatest opportunity to convert-

    • HPV Vaccines companies
    • HPV Vaccines vendors
    • Cancer organizations
    • Sexually transmitted diseases treatment companies
    • Hospitals

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    Frequently Asked Questions (FAQs)

    The HPV vaccines market size is expected to reach USD 11.79 billion in the foreseeable future.

    The HPV vaccines market is expected to witness an impressive growth of 16.1% CAGR in the coming years.

    Lumetrics (The U.S), Marco (The U.S), Voptica (Spain), AMICO GROUP (UAE), NIDEK (Japan), Hanson Instruments (UK), Alcon (Switzerland), Carl Zeiss (Germany), Essilor (France), and Johnson & Johnson Visioncare Inc. (US) are among the key players in the HPV Vaccines Market.

    North America Witnessed highest share in the HPV vaccines market in 2020.

    The polyvalent segment accounted for the highest share in the HPV vaccines market in 2020.

    Rising prevalence of cervical cancer among women, the growing need to reduce HPV infections are the factors driving the growth of HPV vaccines market.

    HPV Vaccines companies, HPV Vaccines vendors, Cancer organizations, Sexually transmitted diseases treatment companies, Hospitals are the target audience in the HVP vaccines market.

    •